Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Genetic deletion of granzyme B does not confer resistance to the development of spontaneous diabetes in non-obese diabetic mice.

Kobayashi M, Kaneko-Koike C, Abiru N, Uchida T, Akazawa S, Nakamura K, Kuriya G, Satoh T, Ida H, Kawasaki E, Yamasaki H, Nagayama Y, Sasaki H, Kawakami A.

Clin Exp Immunol. 2013 Sep;173(3):411-8. doi: 10.1111/cei.12134.

2.

Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules.

Balasa B, Van Gunst K, Jung N, Balakrishna D, Santamaria P, Hanafusa T, Itoh N, Sarvetnick N.

J Immunol. 2000 Sep 1;165(5):2841-9.

3.

Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.

Matsumoto M, Yagi H, Kunimoto K, Kawaguchi J, Makino S, Harada M.

Cell Immunol. 1993 Apr 15;148(1):189-97.

PMID:
8098666
4.

CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.

Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV.

Cell Immunol. 2005 May;235(1):1-11. Epub 2005 Aug 24.

PMID:
16122720
5.

A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity.

Qin HY, Mukherjee R, Lee-Chan E, Ewen C, Bleackley RC, Singh B.

Int Immunol. 2006 Jul;18(7):1001-15. Epub 2006 May 4.

PMID:
16675487
6.

Granzyme B is dispensable in the development of diabetes in non-obese diabetic mice.

Mollah ZU, Graham KL, Krishnamurthy B, Trivedi P, Brodnicki TC, Trapani JA, Kay TW, Thomas HE.

PLoS One. 2012;7(7):e40357. doi: 10.1371/journal.pone.0040357. Epub 2012 Jul 9.

7.
8.

Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.

Yoon JW, Jun HS.

Ann N Y Acad Sci. 2001 Apr;928:200-11. Review.

PMID:
11795511
9.
10.

Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.

Silva DG, Petrovsky N, Socha L, Slattery R, Gatenby P, Charlton B.

J Immunol. 2003 May 15;170(10):4996-5002.

11.

Beta-cell apoptosis in an accelerated model of autoimmune diabetes.

Augstein P, Stephens LA, Allison J, Elefanty AG, Ekberg M, Kay TW, Harrison LC.

Mol Med. 1998 Aug;4(8):495-501.

12.
14.

Significant role for Fas in the pathogenesis of autoimmune diabetes.

Su X, Hu Q, Kristan JM, Costa C, Shen Y, Gero D, Matis LA, Wang Y.

J Immunol. 2000 Mar 1;164(5):2523-32.

15.
17.
18.

Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice.

Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P.

J Exp Med. 1997 Nov 17;186(10):1663-76.

19.

Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.

Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL.

J Immunol. 2001 Jul 15;167(2):1081-9.

20.

Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.

Gregori S, Giarratana N, Smiroldo S, Adorini L.

J Immunol. 2003 Oct 15;171(8):4040-7.

Supplemental Content

Support Center